Syndax Pharmaceuticals Inc (SNDX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US87164F1057
Syndax Pharmaceuticals Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 172.35 m USD |
| Operating income | -273.08 m USD |
| EBIT | -307.71 m USD |
| Net income | -285.42 m USD |
| Diluted EPS – continuing operations | -3.29 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
More stocks
- TENNANT CO (TNC)
- Pacific Horizon Investment Trust PLC (PHI.L)
- Hunan Valin Wire & Cable Co Ltd (001208.SZ)
- United Corporations Limited (UNC.TO)
- Gold.com, Inc. (GOLD)
- Shenzhen Fine Made Electronics Group Co Ltd (300671.SZ)
- CHAPTERS Group (CHG.DE)
- SUBURBAN PROPANE PARTNERS LP (SPH)
- Keel Infrastructure Corp. (KEEL)
- Dalian Dalicap Technology Co Ltd (301566.SZ)
- Basilea Pharmaceutica AG Allschwil (BSLN.SW)
- Changzhou Aohong Electronics Co. Ltd. (605058.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.